Management of Antiretroviral-Related Neuropsychiatric Adverse Effects

Management of Antiretroviral-Related Neuropsychiatric Adverse Effects

Saved in:

Bibliographic Details
Main Author:	Anita Rachlis
Format:	Article
Language:	English
Published:	Wiley 2006-01-01
Series:	Canadian Journal of Infectious Diseases and Medical Microbiology
Online Access:	http://dx.doi.org/10.1155/2006/134206
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Analysis of postmarketing neuropsychiatric adverse events of avapritinib based on the FDA adverse event reporting system
by: Wei Mao, et al.
Published: (2025-01-01)

Neuropsychiatric adverse events associated with Glucagon-like peptide-1 receptor agonists: a pharmacovigilance analysis of the FDA Adverse Event Reporting System database
by: Wenchao Lu, et al.
Published: (2025-01-01)

The Impact of Herbal Drug Use on Adverse Drug Reaction Profiles of Patients on Antiretroviral Therapy in Zimbabwe
by: Tinashe Mudzviti, et al.
Published: (2012-01-01)

Linking Mitochondria to Synapses: New Insights for Stress-Related Neuropsychiatric Disorders
by: Freddy Jeanneteau, et al.
Published: (2016-01-01)

Introduction
by: Anita Rachlis
Published: (2007-01-01)

Canadian Expert Panel Recommendations on the Management of CNS Symptoms Related to Efavirenz
by: M John Gill, et al.
Published: (2001-01-01)

Neuropsychiatric symptoms in Alzheimer’s disease
by: J. Vegytė, et al.
Published: (2024-02-01)

Exploring neuropsychiatric symptoms in Friedreich ataxia
by: Simona Karamazovova, et al.
Published: (2024-11-01)

Clinical practice guidelines on cognition in neuropsychiatric disorders and management of long-stay patients
by: Sujit Sarkhel, et al.
Published: (2025-01-01)

The Many Faces of Stress: Implications for Neuropsychiatric Disorders
by: Laura Musazzi, et al.
Published: (2016-01-01)

Neuropsychiatric disorders in Wilson’s disease: literature review
by: S. Galnaitytė, et al.
Published: (2023-10-01)

Neuropsychiatric Involvement in Juvenile-Onset Systemic Lupus Erythematosus
by: Mohammad-Amin Khajezadeh, et al.
Published: (2018-01-01)

The role of glutamine in supporting gut health and neuropsychiatric factors
by: Brett J. Deters, et al.
Published: (2021-03-01)

Neuropsychiatric Disorder Associated with Group G Streptococcus Infection
by: Rie Okumura, et al.
Published: (2018-01-01)

A Case of “Refractory” Neuropsychiatric Lupus Responsive to Anticoagulation
by: Rui Wu, et al.
Published: (2017-01-01)

Myxedema Psychosis: Neuropsychiatric Manifestations and Rhabdomyolysis Unmasking Hypothyroidism
by: Sundus Sardar, et al.
Published: (2020-01-01)

Neuropsychiatric Symptoms in Patients with Idiopathic Normal Pressure Hydrocephalus
by: Yumiko Kito, et al.
Published: (2009-01-01)

Gut–brain axis and neuropsychiatric health: recent advances
by: Ceymi Doenyas, et al.
Published: (2025-01-01)

Incidence of Severe Hepatotoxicity Related to Antiretroviral Therapy in HIV/HCV Coinfected Patients
by: Emily L. Heil, et al.
Published: (2010-01-01)

Methamphetamine Use: A Narrative Review of Adverse Effects and Related Toxicities
by: Amber N. Edinoff, et al.
Published: (2022-09-01)

Quetiapine-related weight loss: Report of a rare adverse effect
by: Nicodemus Okwudili K Obayi, et al.
Published: (2018-07-01)

Atypical Neuropsychiatric Presentation in a Patient Expecting Liver Transplantation
by: Laury Chamelian, et al.
Published: (2018-01-01)

Neuropsychiatric Symptoms in Parkinson's Disease with Mild Cognitive Impairment and Dementia
by: Iracema Leroi, et al.
Published: (2012-01-01)

D8/17 Monoclonal Antibody: An Unclear Neuropsychiatric Marker
by: Astrid Morer, et al.
Published: (2005-01-01)

Intracranial closed-loop neuromodulation as an intervention for neuropsychiatric disorders: an overview
by: Jenna Langbein, et al.
Published: (2025-01-01)

Reducing maladaptive behavior in neuropsychiatric disorders using network modification
by: Nicholas M. Timme
Published: (2025-01-01)

Neuropsychiatric symptoms and specific cognitive domains in mild cognitive impairment
by: Lucas Luchesi Barnes, et al.
Published: (2025-01-01)

Antiretroviral Therapy for HIV-2 Infection: Recommendations for Management in Low-Resource Settings
by: Kevin Peterson, et al.
Published: (2011-01-01)

Treatment of Severe Odynophagia with Long-Acting Topical Nitroglycerin Ointment in a Patient with Acquired Immune Deficiency Syndrome
by: Young-In Kim, et al.
Published: (1993-01-01)

Clinical practice guidelines – An overview of cognitive remediation for various neuropsychiatric disorders
by: Shiv Gautam, et al.
Published: (2025-01-01)

Course of Neuropsychiatric Symptoms during Flares of Systemic Lupus Erythematosus (SLE)
by: Gareth Garrett, et al.
Published: (2017-01-01)

Neuropsychiatric Symptoms in Clinically Defined Parkinson’s Disease: An Updated Review of Literature
by: Paloma Macías-García, et al.
Published: (2022-01-01)

A volumetric study of the choroid plexus in neuropsychiatric systemic lupus erythematosus
by: Hu Liu, et al.
Published: (2025-01-01)

Phenome-wide association studies between SERINC2 and neuropsychiatric disorders
by: Ping Liu, et al.
Published: (2025-01-01)

Challenges in Initiating Antiretroviral Therapy in 2010
by: Cécile L Tremblay, et al.
Published: (2010-01-01)

Effect of home environment on neuropsychiatric development in preterm infants discharged from NICU at 18 months corrected age
by: Yuan Tian, et al.
Published: (2025-01-01)

Relationships between the menstrual cycle and neuropsychiatric and physical symptoms in females with Tourette syndrome
by: Daisy T. Noriega-Makarskyy, et al.
Published: (2025-02-01)

Insufficient Plasma Melatonin and Its Association With Neuropsychiatric Impairments in Patients With T2DM
by: Shuai He, et al.
Published: (2024-01-01)

Hippocampal Atrophy in Systemic Lupus Erythematosus Patients without Major Neuropsychiatric Manifestations
by: Shuang Liu, et al.
Published: (2020-01-01)

Neuropsychiatric Outcome of an Adolescent Who Received Deep Brain Stimulation for Tourette's Syndrome
by: S. J. Pullen, et al.
Published: (2011-01-01)